Spring Bank Pharmaceuticals, Inc.

( )
SBPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.14%148.740.7%$978.30m
PFEPfizer Inc. 1.41%36.680.9%$849.67m
MRKMerck & Co., Inc. 1.21%82.890.7%$707.24m
ABBVAbbVie, Inc. 0.71%87.511.9%$686.32m
BMYBristol-Myers Squibb Co. 0.63%60.281.0%$649.30m
LLYEli Lilly & Co. 1.22%148.041.1%$562.19m
AZNAstraZeneca Plc -0.56%54.801.2%$253.82m
NVSNovartis AG -0.10%86.950.2%$174.03m
GSKGlaxoSmithKline Plc 0.61%37.660.2%$114.15m
NVONovo Nordisk A/S -1.13%69.430.1%$63.36m
RGENRepligen Corp. -2.03%147.547.1%$49.79m
RPRXRoyalty Pharma Plc 0.14%42.070.2%$48.05m
SNYSanofi -0.65%50.170.2%$45.36m
OPKOPKO Health, Inc. 7.58%3.6911.2%$41.04m
TPTXTurning Point Therapeutics, Inc. -1.34%87.360.0%$36.11m

Company Profile

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.